Clinical Trials in Houston

Showing 9501-9520 of 13,620 trials

Intravenous Acetaminophen in Craniotomy

NCT01598701

The purpose of this study is to assess the use of intravenous Acetaminophen (OFIRMEV) as an effective adjunct therapeutic agent in patients undergoing craniotomy.

Postoperative Pain

The University of Texas Health Science Center, Houston100 participantsStarted May 2012

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

NCT00002569

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients who have anaplastic oligodendroglioma.

Brain and Central Nervous System Tumors

Radiation Therapy Oncology Group299 participantsStarted Jul 1994

Mobile, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +92 more locations

Intravenous Acetaminophen in Craniotomy

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Find Trials by Condition in Houston

Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older

A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer

Effect of Three Side Hole Infusion Catheter on CT Image Quality Compared to a Standard Infusion Catheter

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation

Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis

Phase III Cat-PAD Study

Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders

Evaluation of the Accuracy of an Implanted Glucose Sensor

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

A Study of Tasisulam in Treating Participants With Malignant Melanoma

Interactive Telehealth for Pressure Ulcer Prevention After SCI

Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma